Santiala, Alexa Kate T.
HRN: 22-13-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
10/24/2022
10/31/2022
IV
15 Mg
Q24
T/C Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes